Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Activation of NLRP3 Inflammasome by Particles and Crystals: A Continuing Challenge of Immunology and Toxicology. | Annu Rev Pharmacol Toxicol | 2024 | 37708431 | PubTator, text mining | PubMed |
| FABP7 drives an inflammatory response in human astrocytes and is upregulated in Alzheimer's disease. | Geroscience | 2024 | 37688656 | PubTator, text mining | PubMed |
| Nod-like receptors in inflammatory arthritis. | Biomed J | 2024 | 37598797 | PubTator, text mining | PubMed |
| NLRX1: Versatile functions of a mitochondrial NLR protein that controls mitophagy. | Biomed J | 2024 | 37574163 | PubTator, text mining | PubMed |
| Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques. | Nat Biotechnol | 2024 | 37156915 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals the evolution of immune molecules across multiple vertebrate species. | J Adv Res | 2024 | 36871615 | PubTator, text mining | PubMed |
| Novel variants in CIITA caused type II bare lymphocyte syndrome: A case report. | Asian Pac J Allergy Immunol | 2024 | 33386785 | PubTator, text mining | PubMed |
| Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance. | J Immunother Cancer | 2023 | 38315170 | PubTator, text mining | PubMed |
| Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation. | Front Immunol | 2023 | 38283344 | PubTator, text mining | PubMed |
| Switch-Independent 3A: An Epigenetic Regulator in Cancer with New Implications for Pulmonary Arterial Hypertension. | Biomedicines | 2023 | 38275371 | PubTator, text mining | PubMed |
| Genetic Association and Differential RNA Expression of Histone (De)Acetylation-Related Genes in Pemphigus Foliaceus-A Possible Epigenetic Effect in the Autoimmune Response. | Life (Basel) | 2023 | 38255677 | PubTator, text mining | PubMed |
| Limited Effects of Class II Transactivator-Based Immunotherapy in Murine and Human Glioblastoma. | Cancers (Basel) | 2023 | 38201622 | PubTator, text mining | PubMed |
| PD-L1+ diffuse large B-cell lymphoma with extremely high mutational burden and microsatellite instability due to acquired PMS2 mutation. | Cold Spring Harb Mol Case Stud | 2023 | 38199780 | PubTator, text mining | PubMed |
| Comparing the Benefits and Drawbacks of Stem Cell Therapy Based on the Cell Origin or Manipulation Process: Addressing Immunogenicity. | Immune Netw | 2023 | 38188600 | PubTator, text mining | PubMed |
| Mechanism of action and therapeutic targeting of CD30 molecule in lymphomas. | Front Oncol | 2023 | 38188299 | PubTator, text mining | PubMed |
| Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival. | Front Immunol | 2023 | 38179040 | PubTator, text mining | PubMed |
T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantation. | Nagoya J Med Sci | 2023 | 38155626 | PubTator, text mining | PubMed |
| Validation of a Proteomic-Based Prognostic Model for Breast Cancer and Immunological Analysis. | Int J Genomics | 2023 | 38145160 | PubTator, text mining | PubMed |
| Nucleolin Regulates the Expression of Kaposi's Sarcoma-Associated Herpesvirus' Latency-Associated Nuclear Antigen through G-Quadruplexes in the mRNA. | Viruses | 2023 | 38140679 | PubTator, text mining | PubMed |
| Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a "Trojan Horse". | Int J Mol Sci | 2023 | 38139149 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=11